Show simple item record

dc.contributor.authorKIYKIM, Ertuğrul
dc.contributor.authorUygur, Esma
dc.contributor.authorAHMADZADA, Saffa
dc.contributor.authorOge-Enver, Ece
dc.contributor.authorİŞAT, Esra
dc.contributor.authorZÜBARİOĞLU, Tanyel
dc.contributor.authorHOPURCUOĞLU, Duhan
dc.contributor.authorAktuglu-Zeybek, Cigdem
dc.contributor.authorCANSEVER, Mehmet Şerif
dc.date.accessioned2021-12-10T12:56:55Z
dc.date.available2021-12-10T12:56:55Z
dc.identifier.citationZÜBARİOĞLU T., HOPURCUOĞLU D., Uygur E., AHMADZADA S., Oge-Enver E., İŞAT E., CANSEVER M. Ş. , KIYKIM E., Aktuglu-Zeybek C., "The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak", TELEMEDICINE AND E-HEALTH, 2021
dc.identifier.issn1530-5627
dc.identifier.othervv_1032021
dc.identifier.otherav_e3c07c10-bd32-4619-97c9-2250d90b1f5f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/175061
dc.identifier.urihttps://doi.org/10.1089/tmj.2020.0569
dc.description.abstractBackground: The prognosis of phenylketonuria (PKU) in terms of neurocognitive outcome is directly related to lifelong phenylalanine (Phe) levels and adherence to treatment. Monitoring and treatment of PKU patients can be complicated in challenging circumstances as pandemics. This study aims to evaluate the impact of telemedicine for monitoring and treatment of PKU patients on metabolic outcome during coronavirus disease-19 (COVID-19) outbreak.
dc.language.isoeng
dc.subjectReview and Exam Preparation
dc.subjectMedical Assisting and Transcription
dc.subjectMedical Terminology
dc.subjectCommunity and Home Care
dc.subjectCare Planning
dc.subjectHealth Professions (miscellaneous)
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectAile Hekimliği
dc.subjectHealth Policy
dc.subjectHealth Information Management
dc.subjectLeadership and Management
dc.subjectSAĞLIK BAKIM BİLİMLERİ VE HİZMETLERİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleThe Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak
dc.typeMakale
dc.relation.journalTELEMEDICINE AND E-HEALTH
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.contributor.firstauthorID2606915


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record